ST Shenzhen Fu: CMB Life Sciences plans to acquire more than 30% of the shares triggering a mandatory tender offer obligation.

Announcement of Sintai Corporation: CMB Life Science and Technology Co., Ltd. plans to issue new shares to specific parties through the subscription of Sintai Medical Group, resulting in a shareholding percentage exceeding 30% of the issued shares, triggering the obligation of a mandatory offer. According to Article 63 of the Measures for the Acquisition of Listed Companies, with the consent of the shareholders' meeting, investors may be exempted from making an offer. CMB Life Science has promised that the new shares shall not be transferred within 36 months from the date of issuance. This acquisition still needs to go through relevant decision-making and approval procedures, including the approval of the shareholders' meeting and the review of the Shanghai Stock Exchange.